VAP Works, But Milk Inflation Has Erased the Profit—Can Pricing Plug the Hole?
Revenue grew 19% and value-added products surged 32%, yet profit collapsed 39.5%. Management's pricing actions bought one quarter of cover, but the structural milk-cost squeeze requires normalization that's nowhere in sight.
₹1,319.6 Cr
+18.6% YoY
₹30.9 Cr
-39.5% YoY
5.6%
+98 bps QoQ, flat YoY on weak base
Heritage's Q2 earnings revealed a quarter where operational dynamics are at war. Revenue accelerated smartly to ₹1,319.6 Cr, delivered at 18.6% YoY growth, driven by broad-based expansion: VAP surged 32% to now represent 35.4% of the revenue mix, and milk procurement expanded 7% despite price inflation. But beneath that headline is a company being hollowed out by raw-material cost pressures. Profit after tax fell to ₹30.9 Cr, a 39.5% decline versus the prior year, despite the revenue growth. Management attributed this to elevated depreciation from large capex projects capitalized at the fiscal year start—a real factor—but the core issue is simpler: milk procurement costs are rising 11% year-on-year, pricing actions (8% net realization increase) are moving, but they're not keeping pace with the cost creep, and operating leverage is nowhere to be found.
The arithmetic of margin compression
Start with EBITDA. The reported margin of 5.6% sits squarely in low territory for dairy—the industry typically runs at 8–10%. Heritage achieved a sequential improvement of 98 basis points (Q1 to Q2), which management highlighted; but the year-on-year comparison is flat or worse because the prior-year base itself was weak due to an earlier spike in dairy prices. This is the hazard of sequential optics: a rebound off a depressed Q1 can look like progress while the absolute level remains under pressure.
Where the real pain shows is in profit after tax. The 39.5% decline is stark—PAT fell from roughly ₹51 Cr in Q2 of last year to ₹30.9 Cr this quarter. Management is right that depreciation drag is real: large capex projects (procurement networks, ice cream facilities, manufacturing upgrades) capitalized at the start of FY-2027 are now running through the P&L, suppressing reported earnings relative to EBITDA. But that is a technical argument; the fundamental point remains: revenue jumped 19%, but EBITDA barely moved in absolute rupees, and PAT fell. That tells you every extra rupee of revenue is being swallowed by higher raw-material costs.
What management claimed on the call versus what held up
Revenue grew 19% YoY.
Revenue ₹1,319.6 Cr, up 18.6% YoY.
Slightly overstated
EBITDA margin stood at 5.6%, improved 98 bps sequentially.
EBITDA ₹740 Cr, margin 5.6%, +98 bps QoQ confirmed.
Supported
VAP now represents 35.4% of revenue, up from 31.3% YoY.
VAP (ex-ghee/butter) ₹4,510 Cr, 35.4% of revenue. Broader VAP 42.5% incl. ghee/butter.
Supported
8% price increase taken across products to offset procurement inflation.
Milk 6% NR increase, VAP 9–10%, weighted to 8%. Confirmed.
Supported
Elevated procurement costs are a concern; PAT reflects this.
PAT down 39.5% YoY despite 19% revenue growth. Milk costs +11% YoY.
Contradicted—this is not a 'concern,' it's a crisis.
What changed this quarter
VAP contribution upgraded: now 35.4% of revenue (up from 31.3% YoY), growing 32% YoY. Lassi, buttermilk, ice cream, and premium paneer (Nourish+) all scaling. This is the core strategy and it is working.
Milk procurement cost acceleration: ₹47.73/L, +11% YoY versus ~7–8% in Q1. Management expects Q3 to see another 2.4–2.5% increase quarter-on-quarter. No visibility on normalization.
PAT outlook downgraded: Management's prior call implied profitability resilience; Q2 print contradicts that. Capex depreciation is the stated reason, but it masks weak operating leverage.
Margin expansion guidance withdrawn: When asked if 7%+ EBITDA margin is achievable in the next 2–4 quarters, CEO said 'hoping for better if milk prices come down' but made no commitment. Tone shifted from Q1 optimism to pragmatism.
The bull case
VAP expansion is real and broadening. At 32% growth, VAP now accounts for 35.4% of revenue and is touching all categories: curd has crossed 500 tonnes daily, paneer is growing, ice cream is ramping (currently ~₹200 Cr annualized, targeting ₹500 Cr in 6–7 years), and buttermilk and lassi are accelerating. This is a structural shift to higher-margin products that should compress the dependence on low-margin milk. Heritage Nutrivet (a subsidiary) is firing on all cylinders: Q2 revenue up 47% YoY to ₹853 Cr, H1 up 42% to ₹1,581 Cr. Get-A-Way ice cream (71% Heritage stake) is supplying growing volumes to the Alpenvie network.
Management has pricing power: the company took an 8% net-realization increase (milk 6%, VAP 9–10%) this quarter, and higher prices from September onwards are accruing into Q3. Brand strength and regional penetration in curd and fresh dairy remain unmatched; differentiation via VAP and premiumization (Nourish+ paneer with 16–17% volume share) is protecting margins relative to commodity peers.
The organized dairy market is only ~6% penetrated in India, and Heritage is 0.5% of it—headroom for growth is enormous. Large competitors entering the space should help organize the category, not cannibalize Heritage's position in curd and fresh categories where it holds leadership.
The bear case
Milk procurement costs are in a structural uptrend. At 11% YoY, and with Q3 expected to see another 2.4–2.5% increase quarter-on-quarter, the cost curve is not bending. Management calls it 'wait and watch,' hoping for a buffalo milk flush post-Diwali to ease supply, but is transparent that feed-cost inflation, climate stress (El Niño), and farmer income pressures are real and persistent. The 8% price increase Heritage took is a start, but if milk costs continue to rise at 2–3% quarterly, pricing power alone will not plug the gap—consumer elasticity will cap pricing eventually.
Operating leverage is non-existent. Revenue up 19%, but EBITDA margin is dead flat year-on-year and PAT is down 40%. That tells you the company is reinvesting every incremental rupee into higher costs, not converting it to profit. Capex depreciation is a drag, yes, but the real issue is that raw-material inflation is swallowing all operational gains.
Large conglomerate entry into dairy (ice cream, drinkables, milk brands) with scale and low-price strategy is a threat. While Heritage's curd and paneer moats are defensible, a 10x-scale competitor with lower cost of capital can subsidize pricing and take share in VAP categories. Competitive dynamics in ice cream are particularly intense.
The stock is also facing momentum headwinds: down 46.6% from all-time high of ₹727.35, trading below its 20-day moving average (₹402.61 vs ₹388.15 current), and FII ownership has ebbed from 6.16% a year ago to 1.98% now. Short-term institutional sentiment is negative.
Ranked risks
Milk procurement cost inflation structural and accelerating.
HighCosts up 11% YoY, Q3 expected +2.4% QoQ. Driven by feed inflation, climate stress, farmer income pressures—forces outside management control. If costs continue to rise, even aggressive pricing will hit consumer elasticity limits. EBITDA margin recovery depends entirely on cost normalization that has no timeline.
Earnings quality deterioration masked by capex depreciation.
HighPAT down 40% despite revenue up 19% is a red flag. Yes, capex depreciation is a factor, but it masks weak operating leverage. Raw-material inflation is swallowing incremental revenue gains. If this pattern continues, adjusted earnings power is weaker than reported revenue growth implies.
EBITDA margin stuck at 5.6% (low tier) with no inflection path.
HighIndustry runs at 8–10%; Heritage is 250–450 bps below. Management targeted 'high single-digit' EBITDA but offered no commitment when asked if 7%+ is achievable in 2–4 quarters. Tone was 'hoping for better if milk prices come down.' That hedging suggests management itself has low confidence in near-term margin expansion.
Large conglomerate entry into dairy with scale and low-price strategy.
MediumOrganized dairy is only ~6% penetrated; large players can help grow the category but also compete on price and margin. Heritage's curd and paneer moats are defensible, but ice cream faces intense competition from low-cost entrants with deeper pockets.
Milk procurement growth (6% CAGR) vs revenue growth (mid-teens target) mismatch.
MediumAnalyst questioned if 6% procurement volume growth is adequate to support mid-teens revenue growth. Management deflected, citing VAP mix shift and adjacencies. But if milk supply cannot scale with revenue, operational bottlenecks could emerge.
Institutional ownership erosion and valuation downtrend.
MediumFII ownership has declined from 6.16% a year ago to 1.98% now; stock is 46.6% off all-time high and trading below its 20-day moving average. Momentum is negative. The flow dynamics suggest institutional sentiment on the stock is weak given earnings-quality concerns.
How the street is positioned
The market's initial reaction to the Q2 results was muted: the stock rallied 1.95% on day 1 with 46.6% delivery, but the move did not hold with conviction. That lukewarm reception aligns with the fundamental picture: revenue beat headlines but profit collapsed, a contradiction that investors are pricing as uncertainty rather than opportunity.
Heritage is trading at ₹388.15, down 46.6% from its all-time high of ₹727.35, but up 32.7% from its 52-week low of ₹292.55. The stock is below its 20-day moving average (₹402.61) and trades above its 50-day (₹388.01) and 200-day (₹358.81) moving averages. RSI stands at 46.8 (neutral, neither overbought nor oversold). Volume trend is increasing, suggesting growing interest, but directionality is unclear.
Institutional flows tell the story more clearly. FII ownership has eroded significantly: a year ago it was 6.16%; today it sits at 1.98%—a cumulative outflow of 418 basis points. DII ownership is stable and ticked up marginally (from 6.22% to 6.38% in the most recent quarter). Promoter stake remains steady at 41.30%.
The big picture: Heritage is a story the smart money has been quietly exiting. The earnings-quality concerns (PAT down 40% despite revenue up 19%, margin inflection absent, cost inflation structural) have spooked FII flows, and the stock's 46.6% drawdown from ATH reflects that reset. The muted day-1 reaction to Q2 results and the below-SMA-20 trading confirm that the market is treating this as a 'prove it' story, not a 'buy on dip' story.
What to watch next
1 · Q3 milk cost trajectory and pricing accrual
The real watermark. Management expects milk costs to rise 2.4–2.5% quarter-on-quarter in Q3. But it also took price increases in July, August, and September (with September prices 'much higher' than Q2). The key: does the Q3 price accrual (now flowing through) offset the milk cost rise? If EBITDA margin expands materially and PAT stabilizes, confidence in the pricing story rebuilds. If margin stays flat or compresses further despite price hikes, the bear case hardens.
2 · Post-Diwali buffalo milk flush impact
Management is 'hoping' for a supply moderation after Diwali (when buffalo milk traditionally becomes more available). If that flush materializes and milk costs flatten or decline, it could be the relief valve for Q3 and Q4. Conversely, if no flush occurs or costs continue to rise, it signals a structural supply problem, not a cyclical one. This is a data point to watch closely in the next 2–3 weeks.
3 · VAP momentum sustainability and ice cream ramp
VAP grew 32% in Q2 and was already up 4.1% in the first 15 days of Q3 (management disclosed). If that cadence holds through Q3 and Q4, and ice cream volumes continue to scale toward the ₹500 Cr six-year target, the mix-shift story gains legs. But if VAP growth decelerates below 20% or ice cream facility ramp-up hits roadblocks, the bull thesis weakens materially.
The verdict
Heritage Foods is not a broken company—it is a well-run franchise hitting a cyclical cost pressure that is testing its pricing power. VAP expansion, brand strength, and regional moats remain intact. But Q2 demonstrated that neither revenue growth nor mix shift is enough to overcome an 11% procurement cost backdrop. The company is defending margin (EBITDA up 98 bps QoQ) rather than expanding it, and profit is contracting.
That is not step-change deterioration, but it is a pause in the bull case. Management's tone has shifted from Q1 optimism ('calibrated pricing actions,' 'high single-digit EBITDA') to Q2 pragmatism ('hoping' for cost relief, 'wait and watch'). The stock has repriced accordingly—down 46.6% from ATH, below its 20-day moving average, and shedding FII ownership.
The single number to track from here is EBITDA margin trajectory in Q3. If it expands (toward 6%+) despite further milk cost rises, the pricing story is winning and a re-rating upward is plausible. If it stays flat at 5.6% or compresses, operating leverage remains absent and the margin inflection is deferred indefinitely. That will be the arbiter of whether Hold becomes Buy or falls to Sell in the next quarter.
Informational and educational content only. Not investment advice.